when fda approve compass pathways' comp360 psilocybin

    Before July 2027

    when fda approve compass pathways' comp360 psilocybin. Best Yes near 76¢ across 1 platform. Live cross-platform prices. Not financial advice.

    Best Yes: 76¢ · Best No: 31¢ · 1 platform

    • Kalshi: Yes 76¢ / No 31¢

    Before July 2027

    Volume

    $7.5K

    $5 24h

    Platforms

    1

    Cross-platform pricing

    Resolution

    Resolves Jul 1, 2027

    ~380 days left

    Category

    Culture

    76¢CHANCE OF YES71%29%
    Yes
    76¢
    Kalshi
    No
    31¢
    Kalshi

    Opens on best-price platform

    Compare & Trade

    1 platform
    KalshiKalshi
    Best Yes
    Best No
    Yes
    76¢
    No
    31¢
    Vol
    $7.5K
    $5 24h
    Trade on Kalshi

    Price History

    Loading…

    About This Market

    If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes.

    Fee Impact at These Prices

    KalshiKalshiat 76¢: exit costs ~1.28¢/contract
    Full calculator

    Market Details

    ResolutionResolves Jul 1, 2027
    Time Left380 days
    Status● Active
    CategoryCulture

    Sign in to join the discussion

    Sign In